NSN 6550-01-503-3071, 6550015033071 Control Set Human Serum Parts Sourcing
If you have been looking for Bayer Corp parts listed alongside the NSN 6550015033071, ASAP Distribution has you covered with our unmatched inventory of items Control Set Human Serum. With over 2 billion parts readily available for purchase on our website, customers can get competitive pricing offers and rapid lead-times on top NSN part numbers such as 123521. Explore our NSN parts catalog at your leisure, or you may take advantage of our provided search engine to find specific parts in a matter of moments. If you are interested in this particular component or others listed across our website, you may begin the procurement process at any time through the submission of an Instant RFQ form. Using the information that you submit to us, our team of industry experts will quickly craft you a quote that accommodates your individual needs and requirements for NSN 6550015033071.
| Alternative NSN: 6550-01-503-3071 | Item Name : Control Set Human Serum | NIIN: 015033071 | NCB Code: USA (01) |
Part Number's List for NSN 6550-01-503-3071, 6550015033071
| Part No | Manufacturer | Item Name | QTY | RFQ |
|---|---|---|---|---|
| 123521 | Bayer Corp | control set human serum | Avl | RFQ |
Characteristics Data of NSN 6550015033071
| MRC | Criteria | Characteristic |
|---|---|---|
| MRC | Decoded Requirement | Clear Text Reply |
| FEAT | Special Features | 5 READY PACK PRIMARY REAGENT PACKS CONTAINING ADVIA CENTUAR CA19-9 LITE REAGENT AND SOLID PHASE ADVIA CENTUAR CA19-9 MASTER CURVE CARD; SAMPLE VOL 75 UL; FOR IN VITRO DIAGNOSTIC USE IN DETERMINATION OF CA19-9 IN HUMAN SERUM AND TO AID IN MANAGEMENT OF GI CARCINOMA USING THE ADVIA CENTUAR CHEMOLUMINESCENCE ANALYZER IN A HOSPITAL/LAB SETTING; US LAW RESTRICTS THIS DEVICE TO SALE AND DISTRIBUTION BY OR ON THE ORDER OF A DR OR TO A CLINICAL LAB; CA19-9 IS A TUMOR ASSOCIATED ANTIGEN WHICH REACTS W/AN ANTIBODY PRODUCED IN RESPONSE TO IMMUNIZATION W/A HUMAN COLON CANCER CELL LINE; ALSO USEFUL IN DETECTING PANCREATIC CANCER |
